27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Analyst Stock Ratings Initiations

No data available to display
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert

Recent Analyst Stock Rating Initiation News

HC Wainwright & Co. Initiates Coverage On Xtract One Technologies with Buy Rating, Announces Price Target of C$1
HC Wainwright & Co. analyst Scott Buck initiates coverage on Xtract One Technologies (TSX:XTRA) with a Buy rating and announces Price Target of C$1.
Cantor Fitzgerald Initiates Coverage On Perspective Therapeutics with Overweight Rating
Cantor Fitzgerald analyst Louis Chen initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Overweight rating.
Goldman Sachs Initiates Coverage On ArcelorMittal with Neutral Rating, Announces Price Target of $29.6
Goldman Sachs analyst Matt Greene initiates coverage on ArcelorMittal (NYSE:MT) with a Neutral rating and announces Price Target of $29.6.
Evercore ISI Group Reinstates In-Line on Truist Finl, Announces $44 Price Target
Evercore ISI Group analyst John Pancari reinstates Truist Finl (NYSE:TFC) with a In-Line and announces $44 price target.
Northcoast Research Initiates Coverage On Advanced Drainage Systems with Buy Rating, Announces Price Target of $190
Northcoast Research analyst Ryan Connors initiates coverage on Advanced Drainage Systems (NYSE:WMS) with a Buy rating and announces Price Target of $190.
Maxim Group Initiates Coverage On NeuroBo Pharmaceuticals with Buy Rating, Announces Price Target of $10
Maxim Group analyst Jason McCarthy initiates coverage on NeuroBo Pharmaceuticals (NASDAQ:NRBO) with a Buy rating and announces Price Target of $10.
Barclays Reinstates Equal-Weight on Chart Industries, Announces $193 Price Target
Barclays analyst David Anderson reinstates Chart Industries (NYSE:GTLS) with a Equal-Weight and announces $193 price target.
B of A Securities Initiates Coverage On Sutro Biopharma with Buy Rating, Announces Price Target of $12
B of A Securities analyst Tazeen Ahmad initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Buy rating and announces Price Target of $12.
TD Cowen Initiates Coverage On Ares Management with Buy Rating, Announces Price Target of $154
TD Cowen analyst Jason Gabelman initiates coverage on Ares Management (NYSE:ARES) with a Buy rating and announces Price Target of $154.
TD Cowen Initiates Coverage On LanzaTech Global with Hold Rating, Announces Price Target of $3
TD Cowen analyst Jason Gabelman initiates coverage on LanzaTech Global (NASDAQ:LNZA) with a Hold rating and announces Price Target of $3.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free